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Molecular motors are fundamental to neuronal mor-
phogenesis and function. However, the extent to
which molecular motors are involved in higher brain
functions remains largely unknown. In this study,
we show that mice deficient in the kinesin family
motor protein KIF13A (Kif13a/ mice) exhibit ele-
vated anxiety-related behavioral phenotypes, prob-
ably because of a reduction in 5HT1A receptor
(5HT1AR) transport. The cell-surface expression level
of the 5HT1AR was reduced in KIF13A-knockdown
neuroblastoma cells and Kif13a/ hippocampal
neurons. Biochemical analysis showed that the
forkhead-associated (FHA) domain of KIF13A and
an intracellular loop of the 5HT1AR are the interface
between the motor and cargo vesicles. A minimotor
consisting of the motor and FHA domains is able to
transport 5HT1AR-carrying organelles in in vitro re-
constitution assays. Collectively, our results suggest
a role for this molecular motor in anxiety control.INTRODUCTION
Neurotransmitter receptors are membrane proteins that are
essential for neurons to communicate through chemical signals
(Nicholls, 2001; Snyder, 2009). Because neurotransmitter recep-
tors are fundamental for brain function and animal behavior, their
dysfunction is thought to underlie many psychiatric disorders
(Nicholls, 2001). Genetic alteration of neurotransmitter receptors
has been reported to induce abnormal behavior in mice (Aiba
et al., 1994; Li et al., 1994; Parks et al., 1998; Ramboz et al.,
1998; Tsien et al., 1996). Serotonin (5-hydroxytryptamine
[5-HT]) receptors are one class of neurotransmitter receptor.
This class is known to be involved in various neurological
processes, such as aggression, anxiety, and mood. Among
the serotonin receptor family proteins, the 5HT1A receptor
(5HT1AR) is expressed in the cerebral cortex, hippocampus,
amygdala, and raphe nucleus, and mediates inhibitory neu-
rotransmission. 5HT1AR-knockout (Htr1a
/) mice show
elevated-anxiety phenotypes in anxiety paradigms such as the
open-field and elevated-plus-maze tests (Heisler et al., 1998;CParks et al., 1998; Ramboz et al., 1998). In addition to neu-
rotransmitter receptors, many molecular mechanisms (e.g.,
gene expression, translation, and protein phosphorylation) are
involved in higher brain functions. Although intracellular trans-
port controls various aspects of neuronal phenomena, the extent
to which intracellular transport is involved in the higher brain
functions remains largely unknown. Kinesin superfamily proteins
(KIFs) are ATP- and microtubule-dependent molecular motor
proteins that control intracellular transport (Hirokawa et al.,
2010; Vale, 2003; Verhey and Hammond, 2009). Recent studies
showed the involvement of KIFs in some higher brain functions
(Kondo et al., 2012; Yin et al., 2011). KIF13A was reported to
be a motor protein that transports the mannose-6-phosphate
receptor in fibroblasts (Nakagawa et al., 2000). KIF13A is also
involved in cytokinesis and endosome-to-melanosome transport
in melanocytes (Delevoye et al., 2009; Sagona et al., 2010).
Although KIF13A was originally identified from the brain comple-
mentary DNA (cDNA) library, the role of KIF13A in neuronal cells
remains elusive. For this study, we generated KIF13A knockout
(Kif13a/) mice and analyzed the function of KIF13A in vivo.
Kif13a/ mice showed elevated-anxiety phenotypes in behav-
ioral analyses. We present biochemical and cell biological
evidence that KIF13A transports the 5HT1AR in neurons. This
report suggests the importance of a molecular motor in mood
control.
RESULTS
Generation of Kif13a/ Mice
We performed homologous recombination in embryonic stem
cells using a targeting vector (Figure S1A), and used the targeted
embryonic stem cells to generate Kif13a/mice. We confirmed
correct gene targeting by southern blotting (Figure S1B),
genomic PCR (Figure S1C), and western blotting with an anti-
KIF13A antibody (Figure 1A). The KIF13A band was diminished
in Kif13a/ brain lysate (Figure 1A). KIF13A was originally
identified from a brain cDNA library and abundantly expressed
in the brain (Nakagawa et al., 1997). To test whether KIF13A is
expressed in neurons, we fixed cultured hippocampal neurons
and stained them with an anti-KIF13A antibody. To exclude
nonspecific signal, the antibody was preabsorbed by acetone
powdermade fromKif13a/ tissues.We observed positive fluo-
rescent signal in the cytoplasm of hippocampal neurons (Figures
1B and 1C). No signal was detected in Kif13a/ neuronsell Reports 3, 509–519, February 21, 2013 ª2013 The Authors 509
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Figure 1. Expression of KIF13A in the Mouse Brain
(A) KIF13A expression was analyzed by western blotting using brain ex-
tract from Kif13a+/+ (+/+) and Kif13a/ (–/–) mice. An anti-KIF13A antibody
was used.
(B–E) Hippocampal neurons from Kif13a+/+ (B and C) and Kif13a/ (D and E)
mice, cultured for 12 days, were fixed and stained with an anti-KIF13A
antibody that was preabsorbed with acetone powder made from Kif13a/
tissues (B and D). The neuronal cytoplasm was stained. Neurons were
510 Cell Reports 3, 509–519, February 21, 2013 ª2013 The Authors(Figures 1D and 1E). The Kif13a/ mice developed and grew
normally (Figure S1D). Nuclear staining revealed that the number
of multinucleated cells was not increased (Figures S1F–S1K),
which is not consistent with previous results fromKIF13A-knock-
down experiments (Sagona et al., 2010). The localization of
b-adaptin and the mannose-6-phosphate receptor was unal-
tered in Kif13a/ fibroblasts (Figures S1L–S1O). Furthermore,
the coat color, which is a good marker of melanocyte function,
was unaffected (Figure S1D). Because the expression of
KIF13A was detected in cultured hippocampal neurons, we per-
formed in situ hybridization to reveal the distribution of KIF13A in
the brain. We observed that KIF13A was broadly expressed in
the hippocampus, thalamus, and cortex (Figure 1F). Kif13a/
brain tissue served as a negative control (Figure 1G). We
observed strong expression of KIF13A in the hippocampus
(Figures 1H and 1I); however, the brain morphology in KIF13A-
knockout mice was unaffected (Figures 1J, 1K, and S1P–S1W).
Kif13a/ Mice Show Abnormal Responses in Anxiety
Paradigms
Although KIF13A is broadly expressed in neurons, the Kif13a/
mice grew normally without any gross anatomical defects of the
brain (Figure 1). Thus, we conducted a series of behavioral anal-
yses. In these tests, we detected significant differences between
Kif13a/ and wild-type (WT) mice in open-field and elevated-
plus-maze tests (Figure 2). In the open-field test, mice were
placed in an open field and their behavior was observed.
Kif13a/ mice were less active than WT mice in terms of the
total distance traveled (40.12 ± 3.74 m and 28.03 ± 2.26 m,
respectively; mean ± SEM, p < 0.05, t test; Figure 2A). The
Kif13a/ mice entered into the central region less often than
theWTmice (10.12%± 0.64%and 6.42% ± 0.33%, respectively;
mean ± SEM, p < 0.05, t test; Figure 2B). The Kif13a/ mice
spent less time in the center of the open field compared with
the WT mice (7.01% ± 0.89% and 2.98% ± 0.23%, respectively;
mean ± SEM, p < 0.05, t test; Figure 2C). TheKif13a/mice also
spent less time crossing the center than the WT mice (1.90 ±
0.17 s and 1.41 ± 0.14 s, respectively; mean ± SEM, p < 0.05,
t test; Figure 2D). These data indicate that Kif13a/ mice
demonstrate higher anxiety than WT mice. In the elevated-
plus-maze test, Kif13a/ mice spent significantly less time in
the open arms than the WT mice (26.96 ± 1.97 s and 16.83 ±
3.00 s, respectively; mean ± SEM, p < 0.05, t test; Figure 2E).
In addition,Kif13a/mice entered the open arms less frequently
than the WT mice (5.42 ± 0.71 times and 3.42 ± 0.42 times,
respectively; mean ± SEM, p < 0.05, t test; Figure 2F). One
possible explanation for these results is that motor and spatial
coordination is affected by the loss of KIF13A. We usedcounterstained with the neuronal marker b3-tubulin (C and E). The scale bar
indicates 50 mm.
(F–I) In situ hybridization was performed using Kif13a-antisense riboprobes on
Kif13a+/+ (+/+) (F and H) and Kif13a/ (–/–) mouse brains (G and I). Scale bars
indicate 500 mm and 160 mm, respectively.
(J and K) Brains dissociated from 8-week-old mice were fixed, sectioned, and
stained with H&E. Representative images of sections from Kif13a+/+ (J) and
Kif13a/ (K) mice are shown. Scale bars indicate 500 mm.
See also Figure S1.
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Figure 2. Kif13a/ Mice Show Elevated-
Anxiety Phenotypes
(A–D) Open-field test. (A) The total distance trav-
eled in 10 min was normalized to locomotor
activity; Kif13a/ mice were less active than
Kif13a+/+ mice. (B) The number of center crosses
was normalized to locomotor activity and ex-
pressed as the percentage of total crosses;
Kif13a/ mice entered the center less frequently
than Kif13a+/+mice. (C) Time spent in the center of
the test apparatus is expressed as the percentage
of total time (10 min); Kif13a/ mice spent signif-
icantly less time in the center than Kif13a+/+ mice.
(D) Time per cross indicates the average time
spent in the center of the open field for each entry;
time spent in the center (time per cross) was lower
inKif13a/mice than inKif13a+/+mice. Data were
collected from 12 Kif13a+/+ and 10 Kif13a/male
mice. *p < 0.05, mean ± SEM, t test.
(E and F) Elevated-plus-maze test. A significant
effect of genotype was found for the time spent in
the open arms (E) and the number of entries into
the open arms (F). *p < 0.05, mean ± SEM, t test
for 12 Kif13a+/+ and 12 Kif13a/ male mice.
(G) Rotarod test. Retention time on the rotarod of
6-month-old mice in five successive trials. There
was no difference in retention time between WT
and Kif13a/ mice (n = 12, mean ± SEM, one-
way ANOVA).performance on a rotarod test to assess this possibility (Hamm
et al., 1994). The rotarod test showed no difference between
Kif13a/ and WT mice over five consecutive days of training
(Figure 2G), suggesting that there was no muscle weakness or
lack of motor coordination in Kif13a/ mice. These behavioral
tests showed that a deficiency of KIF13A leads to an elevated-
anxiety phenotype without affecting motor coordination.
Distribution of 5HT1ARs in Kif13a
/ Neurons
The results described above suggest that Kif13a/ mice have
an elevated-anxiety phenotype. Many studies have shown that
defects in the 5-HT pathway lead to such phenotypes.We postu-
lated that 5-HT synthesis and/or release were reduced in the
Kif13a/ brain. To test this, we used ELISAs to compare the
amount of 5-HT in WT and Kif13a/ brain lysates, and in
medium conditioned by WT or Kif13a/ neurons. No significant
differences were detected (Figure 3A). Previous studies showed
that Htr1a/ mice also demonstrate high-anxiety phenotypes
(Heisler et al., 1998; Parks et al., 1998; Ramboz et al., 1998)
that are similar to those observed in Kif13a/ mice. Hence,
we compared the amount of 5HT1AR protein localized on plasma
membranes of WT and Kif13a/ neurons using an antibody that
recognizes an extracellular domain of the 5HT1AR (Azmitia et al.,
1992; Figure 3B). The antibodywas prepared as described previ-
ously, and recognized a 65-kDa protein by western blotting (Fig-
ure S2A), consistent with previous studies (Raymond et al.,
1993a; Zhou et al., 1999). Because 5HT1AR is glycosylated in
cells, the molecular weight is higher than the predicted size.
We studied the 5HT1AR in cultured hippocampal neurons
because its expression in the forebrain, mainly in hippocampal
neurons, can rescue Htr1a/ phenotypes (Gross et al., 2002).
Compared with WT neurons, the labeling intensity was signifi-Ccantly decreased in Kif13a/ neurons (Figures 3C–3E). When
we compared the total expression levels of the 5HT1AR by
western blotting, we found no significant difference (Figures
3F, S2A, and S2B). We then compared the cell-surface expres-
sion of 5HT1ARs in primary hippocampal neurons derived
from WT and Kif13a/ embryos. The cell-surface expression
of 5HT1ARs was significantly reduced in Kif13a
/ neurons,
whereas that of GluR3 was not changed (Figures 3F and 3G).
Another anti-5HT1AR antibody, which recognizes a different
antigen in the 5HT1AR, was used in a cell-surface assay and
confirmed that the cell-surface expression of 5HT1ARs was
reduced in Kif13a/ neurons (Figure S2C). These data suggest
that the surface expression of the 5HT1AR, but not the total
expression level, is changed in Kif13a/ neurons.
Effects of 5-HT Receptor Agonists and Antagonists
on Kif13a/ Neurons
Serotonin receptors are seven-transmembrane domain recep-
tors. These 5-HT receptors, with the exception of the 5-HT3
receptor, are G protein coupled. 5-HT receptors stimulate or
inhibit the production of cyclic AMP (cAMP). Previous studies
showed that the 5HT1AR agonist 8-Hydroxy-2-(di-n-propyla-
mino)tetralin hydrobromide (8-OH-DPAT) stimulates the produc-
tion of cAMP in hippocampal neurons, although the 5HT1AR is
associated with the Gi alpha subunit (Cadogan et al., 1994;
Raymond et al., 1993b). This is caused by the specific cellular
environment of hippocampal neurons (Roth, 2006). Thus,
the cell-surface level of 5HT1AR can be monitored by comparing
the intracellular levels of cAMP in the presence or absence
of 5-HT1AR agonists and antagonists in cultured hippo-
campal neurons. Basal cAMP accumulation in primary hippo-
campal neurons amounted to 18.79 ± 0.72 pmol/ml andell Reports 3, 509–519, February 21, 2013 ª2013 The Authors 511
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Figure 3. Expression of the 5HT1AR Is
Reduced at the Plasma Membrane
(A) ELISAs were performed to compare the
amount of 5-HT in brain lysate and medium
conditioned with cultured neurons. There were no
differences in the total amount in the brain or in
secreted 5-HT levels in cultured neurons between
WT and Kif13a/mice (n = 5, t test, mean ± SEM).
Left: Secreted 5-HT from the medium of primary-
cultured hippocampal cells. Right: Secreted 5-HT
from brain homogenates.
(B) A schematic showing the structure of the
5HT1AR and the antigen. The antibody is able to
recognize the cell-surface 5HT1AR.
(C and D) Cultured hippocampal neurons disso-
ciated from a Kif13a+/+ brain (C) and a Kif13a/
brain (D) were fixed and stained with the anti-
5HT1AR antibody without detergent extraction.
The scale bar indicates 100 mm.
(E) Quantification of mean fluorescent density. The
data are shown as mean ± SD, *p < 0.01, mean ±
SEM, t test, n = 30.
(F) Cell-surface expression of proteins in Kif13a+/+
and Kif13a/ hippocampal neurons. Proteins that
were exposed on the plasma membrane of
cultured hippocampal neurons were biotinylated
and purified. Proteins were analyzed by western
blotting. The amount of cell-surface 5HT1AR was
significantly reduced in Kif13a/ hippocampal
neurons, whereas that of GluR3 was unchanged.
Beta-actin, which is not exposed on the cell
surface, was used as a purification marker.
(G)Statistical analysisof thecell surfaceexpression
in (F). The absence of intracellular protein (actin)
signals verifies the purity of the cell-surface protein
fraction. *p < 0.05, mean ± SEM, t test, n = 5.
See also Figure S2.20.03 ± 1.97 pmol/ml (mean ± SEM, n = 6), respectively, in WT
and Kif13a/ neurons; there was no significant difference
between them. Application of 8-OH-DPAT increased cAMP
formation in WT neurons by 15% (1 mM), 19.8% (10 mM), and
25.6% (100 mM) in a dose-dependent manner, but it did not
significantly increase cAMP formation in Kif13a/ neurons (Fig-
ure 4A). The 5HT1AR antagonist WAY-100635 had no significant
effect on cAMP levels in either WT or Kif13a/ neurons even at
high concentration (100 mM; Figure 4B). This is probably because
cultured neurons are not stimulated by endogenous serotonin
(Ramboz et al., 1998). We also tested other serotonin receptor
agonists and antagonists. There was no difference between
WT and Kif13a/ neurons when we stimulated primary hippo-
campal cultures with the 5HT1B agonist CP-93129 (Figure S3A),
the 5HT1B antagonist GR-55562 (Figure S3B), or the 5HT2A/2C
agonist ketanserin (Figure S3C). To assess whether the
elevated-anxiety phenotype of Kif13a/ mice results from the
5HT1AR pathway, we compared the effects of 8-OH-DPAT and
WAY-100635 in the open-field test. We found no significant
effects of 8-OH-DPAT (at 0.1 mg/kg and 1.0 mg/kg) on either
WT or Kif13a/ mice (Figure 4C). It has been shown that
8-OH-DPAT has no effect even on WT behavior in this test
because the serotonin receptors are saturated by endogenous
serotonin in this condition (Ramboz et al., 1998). In contrast,
both doses of WAY-100635 (0.03 mg/kg and 0.3 mg/kg) resulted512 Cell Reports 3, 509–519, February 21, 2013 ª2013 The Authorsin a significant decrease in time spent in the center of the open
field by WT mice. However, WAY-100635 caused no significant
effect in Kif13a/ mice (Figure 4D). These results are similar to
those observed in Htr1a/ mice, suggesting that the function
of 5HT1AR is affected in Kif13a
/ hippocampal cells and the
behavioral abnormality in the open-field test is caused by the
defect of the 5HT1AR.
The Forkhead-Associated Domain of KIF13A Binds
to an Intracellular Loop of the 5HT1AR
Behavioral phenotypes, pharmacological assays, and surface
labeling assays all suggested that the 5HT1AR was altered in
Kif13a/ neurons. Because KIF13A is a molecular motor, we
tested the hypothesis that the 5HT1AR is a cargo of KIF13A
in neurons. First, we performed immunoprecipitation in the
presence of the detergent 3-[(3-cholamidopropyl)dimethylam-
monio]-1-propanesulfonate (CHAPS). The 5HT1AR could be cop-
urified with KIF13A in the presence of 0.3% CHAPS (Figure 5A),
suggesting an association between the two. To test this, we used
yeast two-hybrid assays using an intracellular domain of the
5HT1AR and deletion mutants of KIF13A and the 5HT1AR cloned
into yeast two-hybrid vectors (Figure 5B). The Y2HGold strain of
yeast was transformedwith these vectors and plated onto selec-
tion plates containing 5-bromo-4-chloro-3-indolyl a-D-galacto-
pyranoside (X-a-gal). The results suggested that the intracellular
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(A and B) Effects of 8-OH-DPAT (A) and WAY-
100635 (B) on cellular cAMP formation in cultured
hippocampal neurons. 8-OH-DPAT stimulated
cAMP formation with a dose-response relation-
ship (A). WAY-100635 did not completely inhibit
cAMP formation (B). The effects are expressed as
the percentage of basal cAMP formation. *p <
0.05, mean ± SEM, t test, n = 6.
(C and D) Effect of 8-OH-DPAT (C) and WAY-
100635 (D) in the open-field test. There was no
significant effect of 8-OH-DPAT on Kif13a+/+ or
Kif13a/ mice (C). Although there was a signifi-
cant effect of WAY-100635 on Kif13a+/+ mice in
terms of the mean time spent in the center of the
open field, this antagonist had no effect on
Kif13a/mice (D). *p < 0.05, mean ± SEM, n = 10,
two-way ANOVA.
See also Figure S3.loop of the 5HT1AR interacts directly with the forkhead-associ-
ated (FHA) domain of KIF13A (FHAKIF13A; amino acids 420–604
of KIF13A; Figure 5C). To confirm binding via the FHA domain,
we conducted glutathione-S-transferase (GST) pull-down
assays using FHAKIF13A as bait. The FHA domain of KIF1B
(FHAKIF1B; amino acids 455–629 of KIF1B) was used as a nega-
tive control. GST-FHAKIF13A and GST-FHAKIF1B were expressed
in Escherichia coli and bound to glutathione-sepharose beads.
The beads were incubated with brain lysate, washed, and then
analyzed by SDS-PAGE and western blotting using an anti-
5HT1AR antibody. The GST-FHA
KIF13A beads could precipitate
the 5HT1AR, but the GST-FHA
KIF1B beads could not (Figure 5D).
Other 5-HT receptors could not be purified by GST-FHAKIF13A-
conjugated beads. We confirmed the binding of the KIF13A
full-length fragment and FHA domain with the 5HT1AR by Flag-
tag immunoprecipitation (Figure 5E). These results suggest
that the 5HT1AR is transported by KIF13A probably by direct
binding. To confirm that FHAKIF13A is involved in the transport
of 5HT1ARs, we performed knockdown and rescue experiments
in SK-N-SH human neuroblastoma cells. SK-N-SH cells were
chosen because they endogenously express the 5HT1AR (Fricker
et al., 2005); also, the cells are flat, which makes it easy to
visualize the plasmamembrane localization of the 5HT1AR. Using
microRNA (miRNA) vectors against human KIF13A, we knocked
down endogenous KIF13A expression in SK-N-SH neuroblas-
toma cells. By western blotting, its expression was reduced
to 40% of WT levels (Figure 5F). Because the transfection effi-
ciency was 70%, we thought that the knockdown was suffi-
cient. Then, we used a vector encoding a green fluorescent
protein (GFP)-5HT1AR fusion protein to monitor the localization
of the 5HT1AR. Previous studies have shown that the GFP-fused
5HT1AR is fully functional and mimics the localization of theCell Reports 3, 509–519,endogenous 5HT1AR (Renner et al.,
2007; Carrel et al., 2008; Ghavami
et al., 1999). We cotransfected the GFP-
5HT1AR vector with the miRNA vectors
and incubated them for 3 days. The cells
were then fixed and observed. The GFP-5HT1AR was localized to the plasma membrane in control cells;
however, this receptor accumulated on vesicular structures
around the nucleus in KIF13A-knockdown cells (Figures 5G–
5I). Two independent and different knockdown vectors were
able to induce this effect reproducibly. To show the importance
of the association between the 5HT1AR and FHA
KIF13A by a cell
biological method, we cotransfected Flag-tagged full-length
mouse KIF13A (KIF13Afull), the motor domain of KIF13A
(KIF13A420; amino acids 1–420 of KIF13A), and a minimotor
consisting of the motor domain and FHAKIF13A (KIF13A604;
amino acids 1–604 of KIF13A) into KIF13A-knockdown cells.
Because these constructs were made frommouse source mate-
rial, they were nonreactive to human miRNA vectors and were
expressed normally (Figure 5J). When Flag-KIF13Afull and
Flag-KIF13A604 were expressed, the GFP-5HT1AR was local-
ized on the plasma membrane (Figures 5K and 5M). In contrast,
when Flag-KIF13A420 was expressed, the GFP-5HT1AR accu-
mulated on vesicles around the nucleus (Figure 5L). Collectively,
these data suggest that the FHA domain of KIF13A associates
with the 5HT1AR, and that the interaction is essential for the
transport of this receptor.
Intracellular Transport of the 5HT1AR in Kif13a
/
Neurons
We observed the intracellular transport of the 5HT1AR by
expressing the GFP-5HT1AR fusion protein in hippocampal
neurons. Forty-eight hours after transfection, whereas the
GFP-5HT1AR in WT neurons was localized mainly to the plasma
membrane, the GFP-5HT1AR in Kif13a
/ neurons was con-
centrated in a perinuclear structure (Figures 6A–6H). This struc-
ture partially colocalized with the Golgi marker GM130 (Figures
6E–6H). The accumulation was not observed in WT neurons.February 21, 2013 ª2013 The Authors 513
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Figure 5. The FHA Domain of KIF13A Binds
to the Intracellular Loop of the 5HT1AR
(A) Immunoprecipitation was performed using
normal anti-rabbit IgG (NRG) and the anti-KIF13A
antibody (KIF13A). Input and immunoprecipitated
fractions (IP) were separated by SDS-PAGE,
transferred to a membrane, and blotted with
the anti-KIF13A and anti-5HT1AR antibodies. The
asterisk indicates the IgG bands.
(B) Schematic showing the structure of the 5HT1AR
and KIF13A.
(C) Yeast two-hybrid assays. A positive signal
(blue) was obtained between the FHA domain of
KIF13A and the intracellular domain of the 5HT1AR.
(D) GST pull-down assay. GST-FHAKIF1B andGST-
FHAKIF13A were expressed in E. coli and adsorbed
to glutathione beads. The beads were incubated
with brain lysate, washed, and analyzed by
western blotting using the anti-5HT1AR antibody.
(E) Neuro2A cells were transfected with the indi-
cated constructs and immunoprecipitated with
anti-Flag antibody. Beads were subjected to
western blot analysis with anti-Flag and anti-GFP
antibodies. Left panel: KIF13A constructs used in
this study. Right panel: A representative result
of three independent western blot experiments.
* IgG band.
(F–I) A vector encoding the GFP-5HT1AR was
cotransfected into SK-N-SH human neuroblas-
toma cells with a negative control vector (N.C.) or
two human KIF13A-miRNA vectors (hKIF13A
miRNA01 and hKIF13A miRNA02), cultured for
3 days, and fixed. The scale bar indicates 100 mm.
(J–M) SK-N-SH cells were transfected with the
GFP-5HT1AR, hKIF13A-miRNA01, and Flag-tag-
ged mouse KIF13A mutants, cultured for 3 days,
and then fixed. Blotting shows the expression of
full-length KIF13A, KIF13A420, and KIF13A604.
The scale bar indicates 100 mm.
(N) The number of cells with plasma membrane
localization of the 5HT1AR or cells with perinuclear
aggregation of 5HT1AR was counted and is shown
graphically. n = 30 cells from three independent
transfections.Moreover, it could be rescued by overexpression of the KIF13A-
full fragment and KIF13A604, but not by KIF13A420 (Figure S4).
Next, we performed live-cell imaging of 5HT1AR transport in
neurons. To observe transported vesicles, we observed neurons
8–12 hr after transfection. It was previously shown that the
5HT1AR is exclusively localized to dendrites in hippocampal
neurons (Ghavami et al., 1999). Thus, we anticipated that the
5HT1AR was transported from the cell body to dendrites by
vesicular carriers, as is the case for other neuronal receptors
(Guillaud et al., 2003). However, we observed no anterograde
vesicular movement in dendrites, even in WT neurons (Movie
S1; n = 60 immature and 60 mature neurons; total observation
time was 20 hr). To reduce the background and improve the
observation, we performed fluorescence recovery after photo-
bleaching (FRAP; Nakata et al., 1998). Although anterograde
vesicular transport was not observed, we did observe the
GFP-5HT1AR moving by diffusion onto the dendritic plasma514 Cell Reports 3, 509–519, February 21, 2013 ª2013 The Authorsmembrane (Movie S2). Next, we tried to observe the motility of
the GFP-5HT1AR-positive organelles in the cell body. Tubular
structures moving to the plasma membrane were seen in
5-day-old WT neurons, 12 hr after transfection (Movie S3). The
speed of these organelles was 0.5 ± 0.2 mm/s (n = 25). These
organelles sometimes collided with the plasma membrane,
diminished rapidly, and caused the plasmamembrane to expand
(Movie S4; Figure 6I).We believe that transported organelles fuse
with the plasma membrane, and that the GFP-5HT1AR diffuses
rapidly on the plasma membrane. In contrast, in Kif13a/ cells,
GFP-5HT1AR-containing vesicles tended to accumulate around
the cell body. The motility of the GFP-5HT1AR was significantly
reduced, and the number of 5HT1AR-carrying organelles that
collided with the plasma membrane was significantly reduced
compared with that in WT cells (Movie S3; Figures 6J and 6K).
These data suggest that the 5HT1AR is transported to the plasma
membrane in the cell body, and that the molecular motor is
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Figure 6. Intracellular Transport of the
5HT1AR
(A–H) The GFP-5HT1AR (green) was expressed in
Kif13a+/+ (A–D) and Kif13a/ (E–H) neurons. The
neurons were fixed and then stained with amarker
for the Golgi apparatus (GM130, red).
(I and J) Live-cell imaging of the GFP-5HT1AR
(green) in Kif13a+/+ (I) and Kif13a/ (J) neurons.
Representative still images are shown in (I) and (J).
(K) Number of GFP-5HT1AR-positive organelles
that fused with the plasma membrane. The data
are shown as mean ± SD, n = 11 Kif13a+/+ and
Kif13a/ cells from three independent cultures.
See also Figure S4, and Movies S1, S2, S3, S4,
S6, and S7.KIF13A. To test whether other vesicular markers were affected in
Kif13a/ neurons, we overexpressed GFP-fused glutamate-
binding N-methyl-D-aspartate receptor subunit type 2B (GFP-
NR2B) in primary cultured hippocampal neurons. Time-lapse
recordings revealed that most GFP-NR2B clusters were moving
along dendrites in WT and Kif13a/ neurons. There was no
significant difference in the classification of motility (nonmobile,
vibrating, anterograde, and retrograde) between WT and
Kif13a/ neurons (Figure S4J; Movies S6 and S7). Furthermore,
there was no significant difference in the velocity of anterog-
radely or retrogradely transported GFP-NR2B clusters between
WT and Kif13a/ neurons (Figure S4K; Movies S6 and S7).
In Vitro Reconstitution of 5HT1AR Transport
Finally, to confirm that the 5HT1AR is transported by KIF13A
through the FHA domain, we performed in vitro reconstitution
experiments (Nangaku et al., 1994). KIF13A420 and KIF13A604
were cloned into the pET28a vector, expressed in E. coli, and
purified (Figure 7A). Vesicular fractions containing GFP-5HT1AR
were purified using density gradients. To exclude the possibility
that endogenous KIF13A would affect the results, GFP-5HT1AR
vesicles were prepared from Kif13a/ fibroblasts. Both
KIF13A420 and KIF13A604 could translocate microtubules in
the microtubule-gliding assay, as described previously (Naka-
gawa et al., 2000). The gliding speed of both KIF13A420 and
KIF13A604 was 0.8 ± 0.2 mm/s (mean ± SD) in >30 microtubules,
suggesting that these recombinant proteins have motor activity.
We investigated whether these minimotors can transport GFP-Cell Reports 3, 509–519, F5HT1AR vesicles onto microtubules
in vitro. Taxol-stabilized microtubules
labeled with biotin and tetramethylrhod-
amine were fixed onto avidin-coated
coverslips, and motility buffer containing
GFP-5HT1AR vesicles, purified motors,
and nucleotides were added to the
chamber (Figure S5). KIF13A604 could
translocate GFP-5HT1AR vesicles (Movie
S5; Figures 7B and 7C). The speed of
vesicle movement was 0.7 ± 0.3 mm/s
(mean ± SD, n = 50 tubules and vesicles),
which is consistent with the results from
the microtubule gliding assay. We alsoobserved the movement of both vesicular and tubular organelles
in vitro (Figure 7B). When KIF13A420 was coincubated with vesi-
cles, no vesicular movement was observed. These in vitro assay
data support our findings that KIF13A transports 5HT1AR-
carrying vesicles in neurons, and the FHA domain is the cargo-
binding domain.
DISCUSSION
Anxiety Control by a Molecular Motor
Because anxiety is a complex higher brain function and is
clinically important, its molecular mechanisms have been
studied intensively. Previous studies have demonstrated the
roles of neurotransmitters, receptors, and downstream signaling
in anxiety control (Chen et al., 2001; Hendricks et al., 2003; Park
et al., 2005; Parks et al., 1998; Ramboz et al., 1998). Little atten-
tion has been given to the role of molecular motors and intracel-
lular transport in this process, although recent studies have
revealed that molecular motors regulate higher brain functions
such as learning and memory through intracellular transport
(Kondo et al., 2012; Yin et al., 2011). On the basis of the work
presented here, we suggest that the molecular motor KIF13A
is fundamental to anxiety control. Kif13a/ mice showed
elevated-anxiety phenotypes in the open-field and elevated-
plus-maze tests. Considering that KIF13A has been shown
to be involved in AP-1-dependent mannose-6-phosphate
receptor transport (Nakagawa et al., 2000), cytokinesis
(Sagona et al., 2010), and endosome-to-melanosome transportebruary 21, 2013 ª2013 The Authors 515
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Figure 7. In Vitro Reconstitution Experi-
ments
(A–C) Recombinant motors and GFP-5HT1AR
organelles were purified from E. coli and Kif13a/
fibroblasts, respectively. Tetramethylrhodamine-
and biotin-labeled microtubules were fixed on
avidin-coated glass coverslips. Purified motors,
vesicles, and nucleotides were mixed and dis-
pensed onto the coverslips. Time-lapse observa-
tion was performed using TIRF.
(A) Gel image showing the purification of recom-
binant motors.
(B) Still images showing the motility of the GFP-
5HT1AR-carrying organelles in vitro.
(C) Speed of theGFP-5HT1AR-carrying organelles.
The motility was observed only when KIF13A604
was mixed with 5 mM ATP. The data are shown as
mean ± SD, n = 27.
(D) Model for elevated anxiety in Kif13a/ mice.
(E) Model for intracellular transport of the 5HT1AR
in hippocampal neurons. (a) 5HT1AR-carrying
organelles are transported by KIF13A from the
Golgi apparatus to the plasma membrane in
the cell body. (b) The 5HT1AR diffuses into the
dendritic plasma membrane.
See also Figure S5 and Movie S5.(Delevoye et al., 2009), it was possible that an absence of, or
defects in, these processes might cause the elevated anxiety.
However, we could not detect differences in these phenomena
in Kif13a/ mice, probably owing to functional compensation
by other motors (e.g., KIF5, which also binds to and transports
the AP-1 complex; Schmidt et al., 2009). Many studies have
shown that a single motor transports several cargos, and vise
versa (Hirokawa et al., 2010; Vale, 2003; Verhey and Hammond,
2009). Here, we demonstrate that the 5HT1AR is a cargo of
KIF13A. The amount of cell-surface 5HT1A was significantly
reduced inKif13a/ neurons, although the total expression level
of the 5HT1ARand the amount of 5-HT in the brainwere not signif-
icantly altered. Full-length KIF13A was not required for transport
of the 5HT1AR. The FHA domain of KIF13A directly associated
with the intracellular domain of the 5HT1AR in yeast two-hybrid
assays. In an in vitro reconstitution assay, we showed that516 Cell Reports 3, 509–519, February 21, 2013 ª2013 The Authors5HT1AR-carrying organelles were translo-
cated by a recombinant minimotor con-
sisting of the motor and FHA domains.
The minimotor could rescue mislocaliza-
tion of the 5HT1AR in KIF13A-knockdown
cells. This finding is not surprising,
because other studies have shown that
the full-length KIF is not always required
for intracellular transport (Glater et al.,
2006; Horiguchi et al., 2006; Kanai et al.,
2004). The stalk domain may be involved
in the regulation of transport (Verhey and
Hammond, 2009). In live-cell imaging
experiments, the motility of 5HT1AR-
carrying organelles was changed in
Kif13a/ neurons. The 5HT1AR was con-
centrated to perinuclear vesicular structures in Kif13a/
neurons and KIF13A-knockdown neuroblastoma cells (Figures
5 and S4). Biochemical interactions, reduced motility, and mis-
localization in mutant cells are well-established criteria for deter-
mining themotor–cargo relationship (Hall and Hedgecock, 1991;
Hirokawa et al., 2010; Niwa et al., 2008; Stowers et al., 2002).
Thus, we conclude that the 5HT1AR is a cargo of the molecular
motor KIF13A. Because the 5HT1AR is fundamental to anxiety
control (Gross et al., 2002; Parks et al., 1998; Ramboz et al.,
1998), our findings suggest that a reduced amount of cell-surface
5HT1AR, due to defects in its intracellular transport, is a cause
of the elevated-anxiety phenotypes inKif13a/mice (Figure 7D).
Intracellular Transport of the 5HT1AR
Because the 5HT1AR is an important target in the treat-
ment of mood disorders, the biochemical and pharmacological
properties of the 5HT1AR have been studied extensively (Gordon
and Hen, 2004). However, it remains largely elusive how the
5HT1AR is transported. Expression of the 5HT1AR in hippo-
campal and cortical neurons of Htr1a/ mice can ameliorate
abnormal behavior (Gross et al., 2002), and thus cultured hippo-
campal neurons should be a good model system in which to
address this question (Banker and Goslin, 1991; Dotti and
Banker, 1991). Using this system, a previous study showed
that the 5HT1AR is exclusively transported to dendrites, whereas
the 5HT1BR is transported to both the axons and dendrites in
hippocampal neurons (Roth and Xia, 2004). As a mechanism of
dendritic transport, other investigators and we have shown
that dendritic receptors, such as NR2A and NR2B, are trans-
ported from the cell body to dendrites by vesicular transport
using a dendrite-specific motor (Chu et al., 2006; Guillaud
et al., 2003; Setou et al., 2000). However, this study suggests
that intracellular transport of the 5HT1AR differs from that of other
receptors. In dendrites, we observed only diffusive motion of the
5HT1AR on plasma membranes, not vesicular transport (Movies
S1 and S2; total observation timewas20 hr). This suggests that
the 5HT1AR moves from the cell body to dendrites by diffusion
rather than by vesicular transport. The motility of the 5HT1AR-
carrying organelles was observed mainly in the cell body, and
these organelles probably fuse with the plasma membrane in
the cell body. The 5HT1AR-carrying organelles aremainly tubules
in neurons. Tubular carriers are sometimes reported in other
cases, such as TrkA receptors, synaptic vesicle precursors,
major histocompatibility class II molecules, and recycling endo-
somes (Chow et al., 2002; Nakata et al., 1998; Weigert et al.,
2004). We found that it was technically difficult to stain the
tubular organelles with antibodies, as was previously observed
(Nakata et al., 1998). However, because the GFP-5HT1AR was
transported to the plasma membrane and was functional, we
believe that these structures reflect the endogenous transport
pathway. The 5HT1AR was concentrated to perinuclear vesicular
structures in Kif13a/ neurons and KIF13A-knockdown neuro-
blastoma cells, suggesting that KIF13A is involved in the trans-
port of the 5HT1AR from the Golgi apparatus to the plasma
membrane. It has been suggested that the 5HT1AR is trans-
ported by KIF5B via the YIF1B scaffold protein (Al Awabdh
et al., 2012; Carrel et al., 2008). Because the 5HT1AR is not
completely diminished from the plasma membrane in Kif13a/
neurons, it is possible that KIF5 partially compensates for the
function of KIF13A. It is an open question as to how the
5HT1AR diffuses specifically from the cell body into the dendritic
plasma membrane of hippocampal neurons. One possibility is
that there is a diffusion barrier on the plasma membrane of the
axon initial segment (Hedstrom et al., 2008; Kobayashi et al.,
1992; Nakada et al., 2003). Further studies will be required
to elucidate this process. Another unique characteristic of
5HT1AR transport by KIF13A is that KIF13A transports the
5HT1AR probably by direct binding. Previous studies have shown
that KIFs bind to the membrane proteins in cargos through an
adaptor protein complex (Horiguchi et al., 2006; Nakagawa
et al., 2000; Setou et al., 2000; Wang and Schwarz, 2009). It
has been shown that the FHA domain of KIF13B serves as
a cargo-binding domain (Horiguchi et al., 2006). Considering
that KIF13A transports the mannose-6-phosphate receptor byCthe C-terminal tail domain (Nakagawa et al., 2000), our findings
suggest a mechanism for how one motor recognizes several
cargos.
In conclusion, we have revealed a role for molecular motors in
anxiety. The molecular motor KIF13A could be considered
a potential pharmaceutical target for anxiolytic drugs.
EXPERIMENTAL PROCEDURES
Gene Targeting of Kif13a and Generation of Kif13a/ Fibroblasts
All procedures involving animals were approved by the School of Medicine of
the University of Tokyo, and conformed to the relevant regulatory standards. A
targeting vector was constructed to disrupt the Kif13a gene (Figure S1A).
Kif13a+/ mice were obtained by intercrossing the Kif13a3lox/+ mice with
CAG-Cre strain mice (kindly provided by J. Miyazaki; Sakai and Miyazaki,
1997). Genotypes were determined by genomic PCR. Immortalization of
fibroblasts was achieved by stable transfection with an expression vector
containing SV40 large T antigen.
Behavioral Tests
All researchers who performed animal experiments had the required training,
and all experiments were conducted under the University of Tokyo’s rules
regarding animal experimentation. Adult WT and Kif13a/ male mice (3- to
9-month-old littermates, n = 12) were used throughout the behavioral tests.
ANOVA and t tests were used to determine the effect of genotype on behav-
ioral preference. Open-field, elevated-plus-maze, and rotarod tests were
performed as described previously (Parks et al., 1998).
Histological and Cell Biological Studies
In situ hybridization was performed using a fragment (nucleotides 1–1,260
from the start codon) of the KIF13A cDNA as described previously (Zhou
et al., 2009). Brains were dissected and prepared for hematoxylin and eosin
(H&E) staining as previously described (Takei et al., 2000). Samples were
microphotographed using amicroscope equipped with a digital camera (Leica
Microsystems, Wetzler, Germany). Dissociated hippocampal neurons were
prepared as described previously (Banker and Goslin, 1991). Hippocampal
neurons were transfected by the Ca2+ phosphate method (Jiang and Chen,
2006). Fluorescent signals were observed using a LSM710 confocal micro-
scope (Zeiss).
Antibodies
The anti-KIF13A and anti-5HT1AR antibodies were raised in New Zealandwhite
rabbits using custom antigen peptides as described previously (Niwa et al.,
2008). Anti-GM130 antibody was purchased from BD Biosciences (San
Jose, CA); anti-5HT1AR antibody (1:500, catalog no. 85615), anti-5HT1BR
antibody (1:300, catalog no. 13896), and anti-5HT2C receptor antibody
(1:300, catalog no. 44640) were purchased from Abcam (Cambridge, MA);
and anti-GluR3 antibody (1:300, catalog no. 3437) was purchased from Cell
Signaling (Danvers, MA). These serotonin receptor antibodies were used in
previous studies.
Binding Assays and RNA Interference
Immunoprecipitation, yeast two-hybrid, GST pull-down, and RNA inter-
ference (RNAi) assays were performed as described previously (Niwa et al.,
2008).
ELISA of Secreted 5-HT
Determination of secreted 5-HT was performed using a 5-HT ELISA kit (Enzo
Life Sciences, Farmingdale, NY) according to the manufacturer’s instructions.
In Vitro Reconstitution Assay
An in vitro reconstitution assay was performed as described previously, with
slight modifications (Nangaku et al., 1994). Total internal reflection fluores-
cence (TIRF) microscopy and fluorescence-labeled samples were used
instead of differential interference contrast microscopy.ell Reports 3, 509–519, February 21, 2013 ª2013 The Authors 517
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